Amalgamated Financial’s Thermo Fisher Scientific TMO Stock Holding History

Amalgamated Financial’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$63.1M	Buy	+106,816	New	+$61.4M	0.5%	27

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Financial's TMO Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Thermo Fisher Scientific (TMO) in Q1 2022: 106,816 shares worth $63.1M. The stake represents 0.5% of the portfolio and ranks #27 among its holdings.

2,315 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

Amalgamated Financial held 106,816 shares of Thermo Fisher Scientific worth $63.1M as of Q1 2022.
Thermo Fisher Scientific was a new Amalgamated Financial position in Q1 2022.
Thermo Fisher Scientific made up 0.5% of Amalgamated Financial's portfolio in Q1 2022, its #27 holding.
2,315 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.